Activation of PI3K/Akt Pathway by CD133-p85 Interaction Promotes Tumorigenic Capacity of Glioma Stem Cells

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1217002110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

CD133 Regulates PI3K/AKT Signaling in Glioma Stem Cells

Cancer Discovery
Oncology
2013English

Docetaxel Promotes Cell Apoptosis and Decreases SOX2 Expression in CD133‑expressing Hepatocellular Carcinoma Stem Cells by Suppressing the PI3K/AKT Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

bFGF Promotes Sca‑1+ Cardiac Stem Cell Migration Through Activation of the PI3K/Akt Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway

Oncotarget
Oncology
2017English

McL1 Gene Silencing Promotes Senescence and Apoptosis of Glioma Cells via Inhibition of the PI3K/Akt Signaling Pathway

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

CXCL16/CXCR6 Interaction Promotes Endometrial Decidualization via the PI3K/ AKT Pathway

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2019English

IL-17A Promotes Cell Migration and Invasion of Glioblastoma Cells via Activation of PI3K/AKT Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

CD133+ HCC Cancer Stem Cells Confer Chemoresistance by Preferential Expression of the Akt/PKB Survival Pathway

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Flufenamic Acid Inhibits Adipogenic Differentiation of Mesenchymal Stem Cells by Antagonizing the PI3K/AKT Signaling Pathway

Stem Cells International
Cell BiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy